logo







Home>Companies>Omega-therapeutics-nas-omga


Omega therapeutics (nas: omga)

Omega therapeutics (nas: omga)



Omega Therapeutics (NAS: OMGA) is a biotechnology company focused on developing innovative programmable epigenetic medicines, known as Omega Epigenomic Controllers, to precisely manipulate the human genome for disease treatment and cure.
Sign up today to get real-time market insights on Omega therapeutics (nas: omga) and hundreds of other pre-IPO companies



Omega therapeutics (nas: omga) Overview

Cambridge, MA, United States
2017
Biotech
https://www.omegatherapeutics.com



Omega therapeutics (nas: omga) Live Market Data

$00000000
$00000000




Omega therapeutics (nas: omga) Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
IPO7/30/2021
Series C3/30/2021
Series B7/29/2020
Series A5/1/2017




Omega therapeutics (nas: omga) Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
Flagship PioneeringSeries C, Series BSeries C (2021-03-30)
HarbourVest PartnersSeries BSeries B (2020-07-29)
BlackRock (NYS: BLK)Series CSeries C (2021-03-30)
Irving InvestorsSeries CSeries C (2021-03-30)
Point72 Asset ManagementSeries CSeries C (2021-03-30)




Omega therapeutics (nas: omga) 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Omega therapeutics (nas: omga) data




Omega therapeutics (nas: omga) Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Omega therapeutics (nas: omga) data




Latest Omega therapeutics (nas: omga) News







Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.